The benefit of abciximab in percutaneous coronary revascularization is not device-specific

2000-05-01

The American Journal of Cardiology , Volume 85 - Issue 9 p. 1060- 1064

Additional Metadata
Persistent URL	doi.org/10.1016/S0002-9149(00)00696-2, hdl.handle.net/1765/56760
Journal	The American Journal of Cardiology
Organisation	Department of Cardiology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Bhatt, D., Lincoff, M., Califf, R., Simoons, M., Tcheng, J., Brener, S., … Topol, E. (2000). The benefit of abciximab in percutaneous coronary revascularization is not device-specific. The American Journal of Cardiology, 85(9), 1060–1064. doi:10.1016/S0002-9149(00)00696-2

Publication